As you can see in my CV, my research activity has been centered on the study of nuclear receptors and transcription factors in hormone-dependent tumors. In my Master’s degree I studied the effects of dietary factors in breast cancer initiation and progression in animal models, activity that I complemented teaching to second year medical students at the Autonomous University of Barcelona. Later, during my PhD at the Vall-Hebron Research Institute of Barcelona, my work focused on understanding the non-genomic actions of Estrogen Receptor (ER) in Prostate cancer. All this work resulted in four publications as a first author and in collaborations with other projects. The main interest during my post-doctoral research at Cambridge University (UK) was to understand the mechanisms of resistance for endocrine treatment in luminal breast tumors, which led to four significant publications (i.e. Nature, Nature Genetics). In late 2011 I became young group leader at University of Oslo (non-tenure track position). Over the past six years, I have built a team and I have developed a research program in functional genomics and proteomics of breast, colon and endometrial cancers. Currently, I have been awarded with a 'Ramon y Cajal' contract within the Biomedicine field (ranking: first; scoring: 100 out of 100). In 2019 I will lead a cancer genomics group at the Department of Biomedical Sciencies (Faculty of Medicine; University of Barcelona). My past research group has: (1) a proven track record with a total of 10 papers (i.e. NAR, Nat Commun), (2) successfully established national and international research collaborations and (3) attracted significant external funding from several sources (Norwegian and Spanish funding bodies). In addition, I have trained 3 PhD students and 5 undergraduate students. The scientific and educational supervision was complemented with teaching at the University of Oslo.

Finally, during my professional career I have acquired deep knowledge in: (1) the mechanism that control gene expression, (2) genomics, epigenetics and its importance for gene structure and gene transcription, (3) advanced molecular approaches and methods to investigate critical processes in cells such as gene expression, (4) molecular and cellular mechanisms that lead to cancer and (5) bioinformatics tools to both analyze and represent proteomics and highthroutput sequencing data.